Subsequent chemical lysis of EVs on-chip enabled analysis of intravesicular biomarkers by ELISA, showing that non-small-cell lung cancer patients had a significantly elevated level of IGF-1R than healthy individuals. The gene discussed is IGF1R; the disease is non-small cell lung carcinoma.